27 April 2017
News and Views
Links and Services
The latest issue of the American Journal of Gastroenterology examines the risk of malignancy in Crohn's with various drug therapies.
Dr Gary Lichtenstein and colleagues from Pennsylvania, USA assessed potential as
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors